QGel Information

View Top Employees from QGel

INNOVATING DRUG DISCOVERY QGel is dedicated to making in vitro drug discovery more relevant to in vivo biology. QGel in vitro assays are physiologically relevant because they are based on clonogenically-grown cells within designer microenvironments that favour the expression of physiological features normally only seen in vivo or in the clinic. QGel SA was founded in 2009 and is based in the Lake Geneva region of Switzerland.

Website	https://www.qgelbio.com
Revenue	$5.2 million
Employees	9 (2 on RocketReach)
Founded	2009
Address	Innovation Park, Lausanne, Vaud 1015, CH
Phone	+41 21 694 07 07
Fax	+41 21 560 49 57
Technologies	JavaScript , HTML , PHP +18 more (view full list)
Industry	Biotechnology, Business Services General, Medical Devices, Business Services, Science and Engineering, Collaboration
Web Rank	12 Million
Keywords	Drug Discovery, In Vitro Assays, Cell Culture, Drug Development, Biotechnology, Pharmaceutical Research, Preclinical Testing, 3d Cell Culture, Cancer Research, Tissue Engineering, Regenerative Medicine, Disease Modeling, Drug Screening, Biomedical Research, Pharmaceutical Development, Therapeutic Discovery, Biopharma
Competitors	Thermo Fisher Scientific, BD, Agilent Technologies, Corning Incorporated, Lonza, MilliporeSigma, Sartorius, Promega Corporation, Molecular Devices, Cell Signaling Technology (CST) +31 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies